Cosmo and Glenmark Announce UK MHRA Approval of Winlevi® for Treatment of Acne
Bengaluru: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) ("Cosmo") and Glenmark Pharmaceuticals Limited (Glenmark), a global research-led pharmaceutical company, today announced that Glenmark had received approval from the Medicines!-->…
Read More...
Read More...